The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144.
Blackstone Inc.
BX · a US exchange · USD · Market cap $160.1B · 5,285 employees
Blackstone Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 09:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Blackstone Inc. holds its Markdown at $133.97. The statistical read favours the sellers, held for 303 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 303 days |
| Price at the screen | $133.97 |
| Valuation | 29.97 trailing · 17.89 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.56 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $126.18 fair value estimate, strong competitive moat, 28.60% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 5.8% above the base estimate.
Third-party analyst targets: 21 covering, consensus Buy. The average target sits +5% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBlackstone's Ethical Failing Overshadows Financials
Imagine a financial titan that can move markets, a firm that's as much a part of Wall Street's fabric as the Charging Bull statue. That's Blackstone Inc., an alternative asset manager with a strong moat in private equity and real estate. It stands out with a robust revenue growth of 29%, a profit margin of 23%, and an ROE of 31%, numbers that would typically make investors sit up and take notice.
However, despite these attractive financials, Blackstone fails our ethical screen, a critical measure in today's investing landscape. It's not the numbers that are the issue here, but the firm's business activities that lead to an ethical failing. This is a red flag that goes beyond the allure of high returns and growth prospects.
The market consensus is a buy, with a median target of $140, which is perilously close to the current price, offering little margin of safety. Coupled with the ethical failings, this analysis suggests caution. The allure of strong financial metrics is undeniable, but the ethical dimension is a non-negotiable part of our investment thesis. Analysis, not advice.
| Forward P/E | 17.9xcheap for a company growing this fast |
| Trailing P/E | 30.0xa premium valuation |
| EPS, trailing | 4.47 |
| EPS, forward | 7.49 |
| Revenue growth | +28.6%strong top-line growth |
| Profit margin | 22.7%healthy profit margins |
| Return on equity | 31.4%an exceptional return on shareholder capital |
| Dividend yield | 402.00% |
| Debt to equity | 0.68moderate, manageable leverage |
| Current ratio | 0.87below 1: short-term bills exceed liquid assets |
| Beta | 1.56much more volatile than the market |
| Short interest, float | 0.03% |
| 52-week range | 101.73 - 190.09 |
| Moat | STRONG |
| Market cap | $160.1B |
| Employees | 5,285 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBX trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 10.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Sector Update: Financial Stocks Mixed Late Afternoon MT Newswires · 15h ago
- Sector Update: Financial Stocks Rise Thursday Afternoon MT Newswires · 17h ago
- GFL shares surge on report of PE bidding war Investing.com · 21h ago
- Market Chatter: Blackstone, Alphabet AI Venture Set for $22 Billion Chip Financing MT Newswires · 1d ago
- GOOGL, BX Stock In Focus — Banking Consortium Reportedly Lines Up $22B AI Chip Financing For Blackstone-Alphabet Venture Stocktwits · 2d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | PORAT RUTH M | Director | 438 | $53,974 | |
| 2026-05-01 | SAWHNEY VIKRANT | Officer | 30,014 | $3,775,565 | |
| 2026-04-01 | PORAT RUTH M | Director | 1,961 | · | |
| 2026-04-01 | SAWHNEY VIKRANT | Officer | 129,077 | · | |
| 2026-04-01 | FINLEY JOHN G | Officer | 152,222 | · | |
| 2026-04-01 | BARATTA JOSEPH P | Director | 124,626 | · | |
| 2026-04-01 | BREYER JAMES W | Director | 1,961 | · | |
| 2026-04-01 | CHAE MICHAEL S. | Chief Financial Officer | 152,667 | · | |
| 2026-04-01 | GRAY JONATHAN D. | President | 302,662 | · | |
| 2026-04-01 | PARRETT WILLIAM G | Director | 2,048 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Sale | 15K–50K |
| 15 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 1 May2026 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $121.40 | -2.2% | · | $978 | -2.2% |
| 2 months | $113.78 | +4.3% | $1.16 | $1,053 | +5.3% |
| 3 months | $101.18 | +17.3% | $1.16 | $1,184 | +18.4% |
| 6 months | $150.94 | -21.4% | $2.65 | $804 | -19.6% |
| 1 year | $137.95 | -14.0% | $4.97 | $896 | -10.4% |
| 2 years | $112.49 | +5.5% | $9.02 | $1,135 | +13.5% |
| 3 years | $80.37 | +47.7% | $12.38 | $1,631 | +63.1% |
| 5 years | $80.45 | +47.5% | $20.84 | $1,734 | +73.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.